Skip to content

LEEF-shoe

Plantar pressure and acceptance of the LEEF-shoe in individuals with diabetes-related neuropathy - LEEFshoe

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON58316
Enrollment
30
Registered
2025-06-26
Start date
2026-03-31
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic neuropathy Numbness

Interventions

All participants will receive two pairs of OS, a standard-OS and an additional OS (e.g., the LEEF-shoe), both provided through usual care channels. At handover, plantar pressure measurements will be p

Sponsors

Universitair Medisch Centrum Groningen
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Aged 18 years or olderDiabetes mellitus type 1 or 2IWGDF Risk 2 - 3Prescribed with fully custom-made orthopedic footwear (OS type A)Ability to provide informed consent

Exclusion criteria

Exclusion criteria: Severe foot deformitiesActive Charcot’s neuroarthropathyFoot ulcer or open amputation siteSevere illness, based on clinical judgment by the physicianNot able to walk at least 10 meters uninterrupted

Design outcomes

Primary

MeasureTime frame
The two primary outcomes of the study are peak plantar pressure and wearing time, both compared between the standard-OS and LEEF-shoe. 

Secondary

MeasureTime frame
The secondary outcomes involve user experience and acceptance, assessed through semi-structured focus groups.

Countries

Netherlands

Contacts

Public ContactJ Hijmans

Universitair Medisch Centrum Groningen

j.m.hijmans@umcg.nl0655256225

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Aug 10, 2026